BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aslim EJ, Law YXT, Fook-Chong SMC, Ho HSS, Yuen JSP, Lau WKO, Lee LS, Cheng CWS, Ngo NT, Law YM, Tay KJ. Defining prostate cancer size and treatment margin for focal therapy: does intralesional heterogeneity impact the performance of multiparametric MRI? BJU Int 2021;128:178-86. [PMID: 33539650 DOI: 10.1111/bju.15355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee AYM, Chen K, Tan YG, Lee HJ, Shutchaidat V, Fook-Chong S, Cheng CWS, Ho HSS, Yuen JSP, Ngo NT, Law YM, Tay KJ. Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy-implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer Prostatic Dis 2022. [PMID: 35027690 DOI: 10.1038/s41391-021-00485-3] [Reference Citation Analysis]
2 Dudderidge TJ. Multiparametric magnetic resonance imaging - a crucial imaging tool for considering and planning prostate cancer focal therapy. BJU Int 2021;128:125-6. [PMID: 34318981 DOI: 10.1111/bju.15442] [Reference Citation Analysis]